FDA Inspection 1170504 — Fahimeh Sasan, D.O., P.C.
The FDA completed an inspection of Fahimeh Sasan, D.O., P.C. on May 20, 2022 in Santa Monica, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 20, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Santa Monica, CA (United States)